3The expert committee on the diagnosis and clas-sification of diabetes melitus: report d the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care, 1997,20:1183-1197.
4World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnoses and classification of diabetes mellitus. Geneva, World Health Organization, 1999.
5Vessby B. Dietary fat and insulin action in humans. Br-J-Nutr, 2000, 3 (8): 91-96.
6Wright PR, Lindo JF. The age - prevalence profile of abdominal obesity among patients in a diabetes referral clinic in Jamaica. West-In-dian-Med-J, 1997, 46 (3): 72-75.
7CLSI.Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline Second Edition.EP9-A2,2002,22(19):1～52.
8CLSI.Evaluation of precision performance of qualitative measurement methods Approved Guideline-Second Edition.EP5-A2,2004,24(25):1～38.
9U.S.Department of Health and human Services.Medicare,Medicaid and CLIA program:Regulations implementing the Clinical Laboratory Improvement Amendment of 1988(CLIA).Final rule.Fed Regist,1992,57(40):7 002～7 186.
10Siekmann L.Traceability of Calibration for IVD Industry:Process for Credentialing Reference Materials,Reference Methods and Reference Laboratories in Europe.In:Proceedings of the Workshop on Measurement Traceability for Clinical Laboratory Testing and In Vitro Diagnostic Test Systems.National Institute of Standards and Technology,Gaithersburg,MD,2000,85～101.
10Jellinger PS,Smith DA, Mehta AE,et al. American association ofclinical endoc^inologists, guidelines for management of dyslipidemiaand prevention of atherosclerosis [j], Endocr Pract, 2012, 18(Suppl 1): 1-78.
